Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model.

about

Global cPILOT analysis of the APP/PS-1 mouse liver proteome.

P2860

Q34459615-FC8E22E0-A0EE-4ACC-95FC-C580E9E9817F

P2860

Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model.

Item

http://www.wikidata.org/entity/Q38440340

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model.

@en

type

Item

label

Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model.

@en

prefLabel

Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model.

@en

P1476

Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model.

@en

P2093

Renã A S Robinson

http://www.w3.org/2001/XMLSchema#string

Zhiyun Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Forecasting the global burden of Alzheimer’s disease

Chaperones and folding of MHC class I molecules in the endoplasmic reticulum

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implication

The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013

Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein

Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation.

Class I MHC molecules: assembly and antigen presentation.

Beta-amyloid peptides enhance the proliferative response of activated CD4CD28 lymphocytes from Alzheimer disease patients and from healthy elderly.

CCR6: a biomarker for Alzheimer's-like disease in a triple transgenic mouse model

P304

291-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PMIC.201300130

http://www.w3.org/2001/XMLSchema#string

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24293237

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model.

about

P2860

P2860

Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921